Stein CA - Search Results

1

Targeting angiopoietin-2 signaling in cancer therapy.

Eroglu Z, Stein CA, Pal SK. Eroglu Z, et al. Among authors: stein ca. Expert Opin Investig Drugs. 2013 Jul;22(7):813-25. doi: 10.1517/13543784.2013.793306. Epub 2013 Apr 27. Expert Opin Investig Drugs. 2013. PMID: 23621441 Review.

2

Prolonged therapy with cabazitaxel in an octogenarian with metastatic castration-resistant prostate cancer.

Pal SK, Stein CA. Pal SK, et al. Among authors: stein ca. Clin Genitourin Cancer. 2012 Dec;10(4):274-6. doi: 10.1016/j.clgc.2012.03.007. Epub 2012 May 9. Clin Genitourin Cancer. 2012. PMID: 22575202 Free PMC article.

3

Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.

Pal SK, Yamzon J, Sun V, Carmichael C, Saikia J, Ferrell B, Frankel P, Hsu J, Twardowski P, Stein CA, Margolin K. Pal SK, et al. Among authors: stein ca. Clin Genitourin Cancer. 2013 Jun;11(2):121-7. doi: 10.1016/j.clgc.2012.09.007. Epub 2012 Oct 11. Clin Genitourin Cancer. 2013. PMID: 23062817 Free PMC article.

4

Preoperative therapy for localized prostate cancer: a comprehensive overview.

Hu J, Hsu J, Bergerot PG, Yuh BE, Stein CA, Pal SK. Hu J, et al. Among authors: stein ca. Maturitas. 2013 Jan;74(1):3-9. doi: 10.1016/j.maturitas.2012.10.012. Epub 2012 Nov 14. Maturitas. 2013. PMID: 23158077 Free PMC article. Review.

5

Enzalutamide for the treatment of prostate cancer.

Pal SK, Stein CA, Sartor O. Pal SK, et al. Among authors: stein ca. Expert Opin Pharmacother. 2013 Apr;14(5):679-85. doi: 10.1517/14656566.2013.775251. Epub 2013 Feb 27. Expert Opin Pharmacother. 2013. PMID: 23441761 Free PMC article. Review.

6

Antisense oligonucleotides in cancer.

Castanotto D, Stein CA. Castanotto D, et al. Among authors: stein ca. Curr Opin Oncol. 2014 Nov;26(6):584-9. doi: 10.1097/CCO.0000000000000127. Curr Opin Oncol. 2014. PMID: 25188471 Review.

7

Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer: A Clinical Commentary.

Stein CA. Stein CA. Clin Genitourin Cancer. 2015 Oct;13(5):407-9. doi: 10.1016/j.clgc.2015.05.005. Epub 2015 Jun 6. Clin Genitourin Cancer. 2015. PMID: 26119230 No abstract available.

8

6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.

Zhang X, Castanotto D, Nam S, Horne D, Stein C. Zhang X, et al. Mol Ther. 2017 Jan 4;25(1):79-91. doi: 10.1016/j.ymthe.2016.10.017. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129131 Free PMC article.

9

Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.

Stein CA, Levin R, Given R, Higano CS, Nemeth P, Bosch B, Chapas-Reed J, Dreicer R. Stein CA, et al. Urol Oncol. 2018 Feb;36(2):81.e9-81.e16. doi: 10.1016/j.urolonc.2017.10.018. Epub 2017 Nov 14. Urol Oncol. 2018. PMID: 29150328 Free article. Clinical Trial.

10

Ammonium and arsenic trioxide are potent facilitators of oligonucleotide function when delivered by gymnosis.

Zhang X, Castanotto D, Liu X, Shemi A, Stein CA. Zhang X, et al. Among authors: stein ca. Nucleic Acids Res. 2018 Apr 20;46(7):3612-3624. doi: 10.1093/nar/gky150. Nucleic Acids Res. 2018. PMID: 29522198 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results